Gabrielle M Haeusler
Overview
Explore the profile of Gabrielle M Haeusler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
886
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Walker H, Haeusler G, Cole T, Neeland M, Hanna D, Shanthikumar S
Clin Transl Immunology
. 2024 Sep;
13(9):e70002.
PMID: 39290231
Objectives: Haematopoietic cell transplant (HCT) is a cellular therapy for a group of high-risk children with cancer, immunodeficiency and metabolic disorders. Whilst curative for a child's underlying condition, HCT has...
12.
Walker H, Abbotsford J, Haeusler G, Yeoh D, Ramachandran S, Ng M, et al.
Clin Transl Immunology
. 2024 Sep;
13(9):e70003.
PMID: 39290230
Objectives: Haematopoietic stem cell transplant (HCT) is a cellular therapy that, whilst curative for a child's underlying disease, carries significant risk of mortality, including because of pulmonary complications. The aims...
13.
Yeoh D, Haeusler G, Slavin M, Kotecha R
Expert Rev Hematol
. 2024 Aug;
17(10):679-686.
PMID: 39110722
Introduction: Children receiving treatment for acute myeloid leukemia (AML) are at high risk of invasive fungal disease (IFD). Evidence from pediatric studies support the efficacy of antifungal prophylaxis in reducing...
14.
Wen S, Harris P, Forde B, Permana B, Chatfield M, Lau C, et al.
Clin Infect Dis
. 2024 Jun;
79(3):734-743.
PMID: 38917034
Background: Gram-negative bloodstream infections (GNBSIs) more commonly occur in children with comorbidities and are increasingly associated with antimicrobial resistance. There are few large studies of GNBSIs in children that relate...
15.
Alzard S, Wen J, Huynh N, Shirkhanzadeh S, Tso J, Rabino M, et al.
J Pediatric Infect Dis Soc
. 2024 Apr;
13(6):313-316.
PMID: 38686824
Community Pharmacists (CPs) are easily accessible and can advocate for the appropriate use of antibiotics in children. Semi-structured interviews were conducted with 47 CPs and 46 parents/caregivers. Both groups expressed...
16.
Patel P, Robinson P, Fisher B, Phillips R, Morgan J, Lehrnbecher T, et al.
EClinicalMedicine
. 2024 Apr;
72:102604.
PMID: 38680517
Our objective was to update a clinical practice guideline for the prevention and treatment of infection (CDI) in pediatric patients with cancer and hematopoietic cell transplantation recipients. We reconvened an...
17.
Jain N, Ryan A, Haeusler G, McMullan B, Moore A, Bartlett A, et al.
Pediatr Blood Cancer
. 2024 Apr;
71(7):e31031.
PMID: 38679843
Invasive fungal disease (IFD) occurs less frequently during treatment for solid compared to hematological malignancies in children, and risk groups are poorly defined. Retrospective national multicenter cohort data (2004-2013) were...
18.
Singh N, Douglas A, Slavin M, Haeusler G, Thursky K
J Antimicrob Chemother
. 2024 Feb;
79(3):632-640.
PMID: 38305582
Background: Neutropenic fever (NF) is a common complication in patients receiving chemotherapy. Judicious antimicrobial use is paramount to minimize morbidity and mortality and to avoid antimicrobial-related harms. Objectives: To use...
19.
Zhao Z, Patel P, Slatnick L, Sitthi-Amorn A, Bielamowicz K, Nunez F, et al.
J Clin Oncol
. 2023 Dec;
42(7):832-841.
PMID: 38060973
Purpose: The optimal management of fever without severe neutropenia (absolute neutrophil count [ANC] ≥500/µL) in pediatric patients with cancer is undefined. The previously proposed Esbenshade Vanderbilt (EsVan) models accurately predict...
20.
Diamond Y, Gilsenan M, Wang S, Hanna D, Conyers R, Cole T, et al.
Transpl Infect Dis
. 2023 Dec;
25(6):e14202.
PMID: 38041799
Background: CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy is transforming care for pediatric patients with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL). There are limited pediatric-specific data concerning the...